» Articles » PMID: 36260163

How to Define and Assess the Clinically Significant Causes of Hematuria in Childhood

Overview
Journal Pediatr Nephrol
Specialties Nephrology
Pediatrics
Date 2022 Oct 19
PMID 36260163
Authors
Affiliations
Soon will be listed here.
Abstract

Given the wide diversity of causes of hematuria, ranging from simple urinary tract infections with rapid recovery to severe glomerulonephritis with fast decline in kidney function, it is essential to recognize the underlying disease. The first objective of the assessment is to determine whether the cause of the hematuria is medically significant. The combination of hematuria with proteinuria, the presence of hypertension, or worsening kidney function can represent signs of progressive kidney disease. Differentiating the various causes of hematuria is often simple and obvious based on the clinical signs and gross appearance of the urine. However, in some instances, additional non-invasive investigations, such as ultrasound imaging, urinary red cell morphology, measurement of calcium and other solutes in the urine, evaluation of kidney function, and protein excretion, are needed to elucidate the nature of the hematuria. Taking a detailed family history can help in establishing the underlying cause in cases of familial hematuria. On the other hand, the decision to perform a kidney biopsy in children with asymptomatic hematuria remains a challenging issue for clinicians. Ultimately, the frequency of diagnosis of glomerular involvement causing hematuria may depend on the threshold for performing a kidney biopsy. The following review will focus on the diagnostics of hematuria, starting with difficulties regarding its definition, followed by various means to differentiate between urinary, glomerular, and other causes, and finally reviewing the most common diseases that, due to their frequency or their effect on kidney function, present a diagnostic challenge in everyday practice.

Citing Articles

Feasibility of home-based urine collection in children under 5 years in the ORIGINS birth cohort study: mixed method protocol and sample completion results.

Kidd C, Moumin N, MacRae A, Green T, Silva D, Prescott S BMC Nutr. 2025; 11(1):11.

PMID: 39815361 PMC: 11734364. DOI: 10.1186/s40795-025-00993-8.


Investigating the Prevalence of Hypercalciuria in Children Aged 2-16 Years With Asymptomatic Microscopic Hematuria in 2020 in Tehran Children's Medical Center.

MohammadKhawajah I, Khamene S, Mahboobipour A, Radmehr E, Moghtaderi M Clin Case Rep. 2024; 12(11):e9575.

PMID: 39545136 PMC: 11560804. DOI: 10.1002/ccr3.9575.


Intravesical Agents in the Treatment of Bladder Clots in Children.

Della Corte M, Clemente E, Cerchia E, De Cillis S, Checcucci E, Amparore D Pediatr Rep. 2023; 15(2):282-292.

PMID: 37092476 PMC: 10123654. DOI: 10.3390/pediatric15020024.

References
1.
Nadasdy T, Hebert L . Infection-related glomerulonephritis: understanding mechanisms. Semin Nephrol. 2011; 31(4):369-75. DOI: 10.1016/j.semnephrol.2011.06.008. View

2.
Sethi S, Fervenza F . Standardized classification and reporting of glomerulonephritis. Nephrol Dial Transplant. 2018; 34(2):193-199. DOI: 10.1093/ndt/gfy220. View

3.
Barocas D, Boorjian S, Alvarez R, Downs T, Gross C, Hamilton B . Microhematuria: AUA/SUFU Guideline. J Urol. 2020; 204(4):778-786. DOI: 10.1097/JU.0000000000001297. View

4.
Rodriguez Cuellar C, Wang P, Freundlich M, Filler G . Educational review: role of the pediatric nephrologists in the work-up and management of kidney stones. Pediatr Nephrol. 2019; 35(3):383-397. DOI: 10.1007/s00467-018-4179-9. View

5.
N V, Singh R, Kumari N, Ranjan R, Saini S . A Novel Association Between Coronavirus Disease 2019 and Normocomplementemic Rapidly Progressive Glomerulonephritis-Crescentic Immunoglobulin A Nephropathy: A Report of Two Pediatric Cases. Cureus. 2022; 14(2):e22077. PMC: 8920789. DOI: 10.7759/cureus.22077. View